FundedIQ

Recently Funded Biotechnology & Pharmaceuticals Startups in the United States

Updated Sep 2026

FundedIQ holds 11 funded Biotechnology & Pharmaceuticals startups in the United States (US) and keeps their funding rounds, amounts, investors, industries, locations and company details up to date. This page provides an overview of the Biotechnology & Pharmaceuticals startup funding landscape in the United States, along with the 11 most recently funded Biotechnology & Pharmaceuticals startups in the United States.

Biotechnology & Pharmaceuticals startups in the United States closed 13 funding rounds over the last 24 months, 13 of them in the last 12 months, and raised $770M in disclosed capital. The median disclosed round is $21M, with the middle half of rounds falling between $14M and $63M. Cambridge and La Jolla hold the deepest concentrations of these companies.

Specialized life science funds dominate the capital profile in Cambridge and La Jolla. These investors prioritize early stage milestones over late stage scaling. The concentration of venture capital in these specific cities creates a high barrier for entry. New entrants face a market where institutional backing is a prerequisite for viability.

Biotechnology & Pharmaceuticals funded startup statistics in the United States

Funded Biotechnology & Pharmaceuticals startups in the United States
11
tracked in the database
Funding rounds, last 12 months
13
13 over 24 months
Disclosed capital raised, 24 months
$770M
13 of 13 rounds disclosed an amount
Median round size
$21M
middle half $14M to $63M

Most recent funding round on record: Aug 2026.

11 most recently funded Biotechnology & Pharmaceuticals startups in the United States

11 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

A
Foster City, United States · Biotechnology, Pharmaceuticals
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Series C ·
$120M
O
Austin, United States · Biotechnology, Pharmaceuticals
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Series B ·
$330M
D
Cambridge, United States · Biotechnology, Pharmaceuticals
Dayra Therapeutics manufactures peptide based medicines.
Venture - Series Unknown ·
$20M
C
Farmingdale, United States · Biotechnology, Pharmaceuticals
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Pre-Seed ·
$3.1M
B
San Francisco, United States · Biotechnology, Pharmaceuticals
Bexorg provides a technology platform for central nervous system drug discovery and development.
Series A ·
$23M
A
La Jolla, United States · Biotechnology, Pharmaceuticals
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
Series A ·
$21M
O
Rockville, United States · Biotechnology, Pharmaceuticals
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Series B ·
$50M
O
Scottsdale, United States · Biotechnology, Pharmaceuticals
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
Venture - Series Unknown ·
$14M
A
Cambridge, United States · Biotechnology, Pharmaceuticals
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
Series A ·
$5.0M
S
San Diego, United States · Biotechnology, Pharmaceuticals
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Series C ·
$5.4M
E
La Jolla, United States · Biotechnology, Pharmaceuticals
Enlaza Therapeutics is a biotechnology research company.
Venture - Series Unknown ·
$15M

Where are funded Biotechnology & Pharmaceuticals startups located in the United States?

Where funded Biotechnology & Pharmaceuticals startups in the United States are based, by the city on the company record.

Funding stages of funded Biotechnology & Pharmaceuticals startups in the United States

How the last 24 months of funding rounds for funded Biotechnology & Pharmaceuticals startups in the United States break down by stage.

Stage
Rounds, last 24 months

A further 3 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology & Pharmaceuticals startup funding data in the United States

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 11 funded Biotechnology & Pharmaceuticals startups in the United States currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (0 of 13 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology & Pharmaceuticals startups in the United States is dated Aug 2026.

The table above shows the 11 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology & Pharmaceuticals startups are there in the United States?

FundedIQ tracks 11 funded Biotechnology & Pharmaceuticals startups in the United States. This page lists the 11 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology & Pharmaceuticals startups in the United States raised?

Biotechnology & Pharmaceuticals startups in the United States tracked by FundedIQ have raised $770M in disclosed capital across 13 funding rounds over the last 24 months, including 13 rounds in the last 12 months. 13 of those 13 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which cities have the most funded Biotechnology & Pharmaceuticals startups in the United States?

Cambridge leads with 2 companies, then La Jolla (2), Austin (1) and Farmingdale (1).

What is a typical funding round size for Biotechnology & Pharmaceuticals startups in the United States?

The median disclosed round over the last 24 months is $21M, and the middle half of rounds fall between $14M and $63M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology & Pharmaceuticals startups in the United States?

Series A is the most common labelled stage, with 4 rounds in the last 24 months, ahead of Series B (3) and Series C (2). A further 3 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology & Pharmaceuticals startup funding data in the United States updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology & Pharmaceuticals startups in the United States is dated Aug 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.